Search results for "Enhanced permeability and retention effect"

showing 2 items of 2 documents

Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation.

2017

Abstract In this paper, we describe the preparation of polymeric nanoparticles (NPs) loaded with sorafenib for the treatment of hepatocellular carcinoma (HCC). A synthetic brush copolymer, named PHEA-BIB-ButMA (PBB), was synthesized by Atom Trasnfer Radical Polymerization (ATRP) starting from the α-poly( N -2-hydroxyethyl)- d , l -aspartamide (PHEA) and poly butyl methacrylate (ButMA). Empty and sorafenib loaded PBB NPs were, then, produced by using a dialysis method and showed spherical morphology, colloidal size, negative ζ potential and the ability to allow a sustained sorafenib release in physiological environment. Sorafenib loaded PBB NPs were tested in vitro on HCC cells in order to e…

3003MaleHepatocellular carcinomamedicine.medical_treatmentPharmaceutical Science02 engineering and technologyATRPPharmacology01 natural sciencesDrug Delivery SystemsCopolymerChemistryATRP; Hepatocellular carcinoma; Sorafenib; Tumor targeting; α-Poly(N-2-hydroxyethyl)-DL-aspartamide; 3003Liver NeoplasmsSorafenib021001 nanoscience & nanotechnologyDrug delivery0210 nano-technologymedicine.drugSorafenibNiacinamideCarcinoma HepatocellularCell SurvivalRadical polymerizationIntraperitoneal injectionL-aspartamideMice NudeAntineoplastic AgentsEnhanced permeability and retention effect010402 general chemistryPolymethacrylic AcidsIn vivoCell Line TumormedicineAnimalsHumansneoplasmsProtein Kinase InhibitorsPhenylurea Compoundstechnology industry and agriculturedigestive system diseasesIn vitro0104 chemical sciencesDrug LiberationTumor targetingDelayed-Action PreparationsBiophysicsα-Poly(N-2-hydroxyethyl)-DNanoparticlesα-Poly(N-2-hydroxyethyl)-DL-aspartamidePeptidesJournal of controlled release : official journal of the Controlled Release Society
researchProduct

AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine.

2019

International audience; AGuIX® are sub-5 nm nanoparticles made of a polysiloxane matrix and gadolinium chelates. This nanoparticle has been recently accepted in clinical trials in association with radiotherapy. This review will summarize the principal preclinical results that have led to first in man administration. No evidence of toxicity has been observed during regulatory toxicity tests on two animal species (rodents and monkeys). Biodistributions on different animal models have shown passive uptake in tumours due to enhanced permeability and retention effect combined with renal elimination of the nanoparticles after intravenous administration. High radiosensitizing effect has been obser…

Radiation-Sensitizing AgentsGadoliniummedicine.medical_treatmentGadolinium02 engineering and technologyReview ArticlePharmacologyTheranostic NanomedicineMice0302 clinical medicineMelanomaBrain NeoplasmsMelanomaGeneral Medicine[CHIM.MATE]Chemical Sciences/Material chemistry[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences021001 nanoscience & nanotechnology3. Good health[SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciencesNuclear Medicine & Medical ImagingRadiology Nuclear Medicine and imagingHead and Neck Neoplasms030220 oncology & carcinogenesisToxicity/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being[SDV.IB]Life Sciences [q-bio]/Bioengineering0210 nano-technologyClinical Scienceschemistry.chemical_element[SDV.CAN]Life Sciences [q-bio]/CancerEnhanced permeability and retention effect03 medical and health sciences/dk/atira/pure/subjectarea/asjc/2700/2741SDG 3 - Good Health and Well-being[SDV.CAN] Life Sciences [q-bio]/CancerIn vivo[CHIM.ANAL]Chemical Sciences/Analytical chemistrymedicineAnimalsHumansRadiology Nuclear Medicine and imaging[SDV.IB] Life Sciences [q-bio]/Bioengineeringbusiness.industryCancermedicine.diseaseRadiation therapyClinical trialchemistryNanoparticlesbusinessForecasting
researchProduct